Selvedge Venture — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Exogeneexogene.co.ukApr 2022
Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in
Co-investorsEntrepreneur FirstUnruly CapitalR42 Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.